Fluorescence imaging assisted precise assessment of the depth of myometrial invasion in endometrial cancer lesions

Qiaojun Qu; Huilong Nie; Shuang Hou; Xiaoyong Guo; Feng Wang; Hua Yang; Shangqiu Chen; Panxia Deng; Zhenhua Hu; Jie Tian

doi:10.1002/ctm2.70309

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (5) : e70309 DOI: 10.1002/ctm2.70309

LETTER TO THE JOURNAL

Fluorescence imaging assisted precise assessment of the depth of myometrial invasion in endometrial cancer lesions

Qiaojun Qu ¹^,²
, Huilong Nie ³
, Shuang Hou ³
, Xiaoyong Guo ⁴
, Feng Wang ³
, Hua Yang ³
, Shangqiu Chen ³
, Panxia Deng ³
, Zhenhua Hu ²^,⁵^,⁶
, Jie Tian ²^,⁵^,⁶^,⁷^,⁸

Author information +

History +

PDF

Cite this article

Download citation ▾

Qiaojun Qu, Huilong Nie, Shuang Hou, Xiaoyong Guo, Feng Wang, Hua Yang, Shangqiu Chen, Panxia Deng, Zhenhua Hu, Jie Tian. Fluorescence imaging assisted precise assessment of the depth of myometrial invasion in endometrial cancer lesions. Clinical and Translational Medicine, 2025, 15(5): e70309 DOI:10.1002/ctm2.70309

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021; 31(1): 12-39.

[2]	Jonsdottir B, Marcickiewicz J, Borgfeldt C, et al. Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer—a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Obstet Gynecol Scand. 2021; 100(8): 1526-1533.

[3]	Ota T, Hori M, Onishi H, et al. Preoperative staging of endometrial cancer using reduced field-of-view diffusion-weighted imaging: a preliminary study. Eur Radiol. 2017; 27(12): 5225-5235.

[4]	Cutress RI, McIntosh SA, Potter S, et al. Opportunities and priorities for breast surgical research. Lancet Oncol. 2018; 19(10): e521-e533.

[5]	Hu Z, Fang C, Li B, et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat Biomed Eng. 2020; 4(3): 259-271.

[6]	Shi X, Xu P, Cao C, Cheng Z, Tian J, Hu Z. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor alpha-targeted dual-modal nanoprobe. Eur J Nucl Med Mol Imaging. 2022; 49(13): 4325-4337.

[7]	Zhang Z, Du Y, Shi X, et al. NIR-II light in clinical oncology: opportunities and challenges. Nat Rev Clin Oncol. 2024; 21(6): 449-467.

[8]	Chang B, Li D, Ren Y, et al. A phosphorescent probe for in vivo imaging in the second near-infrared window. Nat Biomed Eng. 2022; 6(5): 629-639.

[9]	Newton AD, Predina JD, Shin MH, et al. Intraoperative near-infrared imaging can identify neoplasms and aid in real-time margin assessment during pancreatic resection. Ann Surg. 2019; 270(1): 12-20.

[10]	Predina JD, Newton AD, Corbett C, et al. A clinical trial of tumorglow to identify residual disease during pleurectomy and decortication. Ann Thorac Surg. 2019; 107(1): 224-232.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.